These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

606 related items for PubMed ID: 26773665

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Intracellular redox-activated anticancer drug delivery by functionalized hollow mesoporous silica nanoreservoirs with tumor specificity.
    Luo Z, Hu Y, Cai K, Ding X, Zhang Q, Li M, Ma X, Zhang B, Zeng Y, Li P, Li J, Liu J, Zhao Y.
    Biomaterials; 2014 Sep; 35(27):7951-62. PubMed ID: 24930850
    [Abstract] [Full Text] [Related]

  • 3. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
    Wu D, Zhu ZQ, Tang HX, Shi ZE, Kang J, Liu Q, Qi J.
    Theranostics; 2020 Sep; 10(21):9808-9829. PubMed ID: 32863961
    [Abstract] [Full Text] [Related]

  • 4. Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance.
    Shao M, Chang C, Liu Z, Chen K, Zhou Y, Zheng G, Huang Z, Xu H, Xu P, Lu B.
    Colloids Surf B Biointerfaces; 2019 Nov 01; 183():110427. PubMed ID: 31408782
    [Abstract] [Full Text] [Related]

  • 5. A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells.
    Shen Y, Li M, Liu T, Liu J, Xie Y, Zhang J, Xu S, Liu H.
    Int J Nanomedicine; 2019 Nov 01; 14():4029-4044. PubMed ID: 31213813
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fabricating polydopamine-coated MoSe2-wrapped hollow mesoporous silica nanoplatform for controlled drug release and chemo-photothermal therapy.
    Chai S, Kan S, Sun R, Zhou R, Sun Y, Chen W, Yu B.
    Int J Nanomedicine; 2018 Nov 01; 13():7607-7621. PubMed ID: 30510420
    [Abstract] [Full Text] [Related]

  • 8. Albumin-MnO2 gated hollow mesoporous silica nanosystem for modulating tumor hypoxia and synergetic therapy of cervical carcinoma.
    Fang J, Wang Q, Yang G, Xiao X, Li L, Yu T.
    Colloids Surf B Biointerfaces; 2019 Jul 01; 179():250-259. PubMed ID: 30978612
    [Abstract] [Full Text] [Related]

  • 9. Intracellular pH-Triggered, Targeted Drug Delivery to Cancer Cells by Multifunctional Envelope-Type Mesoporous Silica Nanocontainers.
    Yang K, Luo H, Zeng M, Jiang Y, Li J, Fu X.
    ACS Appl Mater Interfaces; 2015 Aug 12; 7(31):17399-407. PubMed ID: 26196506
    [Abstract] [Full Text] [Related]

  • 10. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
    Gupta B, Poudel BK, Ruttala HB, Regmi S, Pathak S, Gautam M, Jin SG, Jeong JH, Choi HG, Ku SK, Yong CS, Kim JO.
    Acta Biomater; 2018 Oct 15; 80():364-377. PubMed ID: 30201431
    [Abstract] [Full Text] [Related]

  • 11. Fabrication of high specificity hollow mesoporous silica nanoparticles assisted by Eudragit for targeted drug delivery.
    She X, Chen L, Velleman L, Li C, Zhu H, He C, Wang T, Shigdar S, Duan W, Kong L.
    J Colloid Interface Sci; 2015 May 01; 445():151-160. PubMed ID: 25617610
    [Abstract] [Full Text] [Related]

  • 12. Aerosol technique-based carbon-encapsulated hollow mesoporous silica nanoparticles for synergistic chemo-photothermal therapy.
    Gautam M, Thapa RK, Poudel BK, Gupta B, Ruttala HB, Nguyen HT, Soe ZC, Ou W, Poudel K, Choi HG, Ku SK, Yong CS, Kim JO.
    Acta Biomater; 2019 Apr 01; 88():448-461. PubMed ID: 30818051
    [Abstract] [Full Text] [Related]

  • 13. Enzyme responsive drug delivery system based on mesoporous silica nanoparticles for tumor therapy in vivo.
    Liu Y, Ding X, Li J, Luo Z, Hu Y, Liu J, Dai L, Zhou J, Hou C, Cai K.
    Nanotechnology; 2015 Apr 10; 26(14):145102. PubMed ID: 25789511
    [Abstract] [Full Text] [Related]

  • 14. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
    Ma X, Zhao Y, Ng KW, Zhao Y.
    Chemistry; 2013 Nov 11; 19(46):15593-603. PubMed ID: 24123533
    [Abstract] [Full Text] [Related]

  • 15. A dual-responsive mesoporous silica nanoparticle for tumor-triggered targeting drug delivery.
    Xiao D, Jia HZ, Zhang J, Liu CW, Zhuo RX, Zhang XZ.
    Small; 2014 Feb 12; 10(3):591-8. PubMed ID: 24106109
    [Abstract] [Full Text] [Related]

  • 16. Overcoming acquired drug resistance in colorectal cancer cells by targeted delivery of 5-FU with EGF grafted hollow mesoporous silica nanoparticles.
    Chen L, She X, Wang T, He L, Shigdar S, Duan W, Kong L.
    Nanoscale; 2015 Sep 07; 7(33):14080-92. PubMed ID: 26242620
    [Abstract] [Full Text] [Related]

  • 17. Stepwise-acid-active organic/inorganic hybrid drug delivery system for cancer therapy.
    Chen H, Chen Z, Kuang Y, Li S, Zhang M, Liu J, Sun Z, Jiang B, Chen X, Li C.
    Colloids Surf B Biointerfaces; 2018 Jul 01; 167():407-414. PubMed ID: 29704741
    [Abstract] [Full Text] [Related]

  • 18. Hollow Mesoporous Silica Nanoparticles Gated by Chitosan-Copper Sulfide Composites as Theranostic Agents for the Treatment of Breast Cancer.
    Niu S, Zhang X, Williams GR, Wu J, Gao F, Fu Z, Chen X, Lu S, Zhu LM.
    Acta Biomater; 2021 May 01; 126():408-420. PubMed ID: 33731303
    [Abstract] [Full Text] [Related]

  • 19. Shape-Controlled Hollow Mesoporous Silica Nanoparticles with Multifunctional Capping for In Vitro Cancer Treatment.
    Geng H, Chen W, Xu ZP, Qian G, An J, Zhang H.
    Chemistry; 2017 Aug 10; 23(45):10878-10885. PubMed ID: 28580592
    [Abstract] [Full Text] [Related]

  • 20. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
    Zou Z, He D, He X, Wang K, Yang X, Qing Z, Zhou Q.
    Langmuir; 2013 Oct 15; 29(41):12804-10. PubMed ID: 24073830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.